microbial theranostics - a resistance combatting strategy | 32nd icc
Published 1 year ago • 757 plays • Length 46:52Download video MP4
Download video MP3
Similar videos
-
28:05
icis: key to surviving cancer - medical frontiers
-
1:03:37
sbs-ias ntu | strategies to slow the development of daptomycin resistance in enterococcus faecalis
-
32:44
context therapeutics webinar: claudin 6 x cd3 bispecific antibody data update
-
0:26
antimicrobial peptide encapsulation in cnts - supplementary video 2 [id 335380]
-
12:13
identification of potential new inhibitors of mycobacterium... - jose antonio jimenez - la 2022
-
0:21
3-d ihc: mouse large intestine - tubulin beta 3 (tubb3), cd326 (ep-cam), helix np™ green
-
13:34
4/3/2018 - session 6: d’anci
-
4:44
azacitidine quizartinib for patients with mds and mpns with flt3 or cbl mutation
-
43:42
7 panel3 part1
-
0:56
dr. chavez discusses ibrutinib plus venetoclax in cll
-
1:47
tp53 mutation-induced dysbiosis causes inflammation by impairing sialic acid metabolism
-
2:02
phase ib/iia study of azd4573 and acalabrutinib in patients with r/r dlbcl
-
0:31
virus-specific cd8 t cells migrating across infected neurons that project to the olfactory bulb
-
1:46
dr. tiacci on vemurafenib in combination with rituximab in hcl
-
5:46
ea3163: chemo vs surgery port for organ preservation in t3/t4 sinonasal scc
-
26:11
carbapenem resistant enterobacterales (cre) treatment: do multinational observational studies help?
-
17:29
7/16/2018 - session 3: butterfield
-
2:04
why should you vaccinate in the era of the delta virus?
-
11:16
#breakthesilos & integrate healthcare services for control of #tobacco, #tb, #diabetes (other #ncds)